Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Trelagliptin Succinate Intermediates 865759-24-6,Synthesis Trelagliptin Treat for Type 2 Diabetes CAS 865759-24-6,DPP-4 Inhibitors CAS NO 865759-24-6
Conbott Pharmtech Co.,Ltd. Trelagliptin Succinate Intermediates 865759-24-6,Synthesis Trelagliptin Treat for Type 2 Diabetes CAS 865759-24-6,DPP-4 Inhibitors CAS NO 865759-24-6
Copyright © 2019 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?